ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX ...

The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the ...

The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

Imugene Ltd (ASX:IMU) (OTCMKTS:IUGNF) is a clinical-stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to ...

Developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours.

Developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours.

Immunic (IMUX) announced that IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, demonstrated a ...

Here we highlight a subset of our preferred stocks from the screener. Overview: Articore Group Limited operates as an online marketplace for art and design products across Australia, the United ...

Learn More S&P/ASX 200 Index (ASX: XJO) stocks are trading just inside the green at 8,419.7 points in late afternoon trade on Tuesday. The ASX 200 dipped then flipped in early trading after a sell ...

What is the current share price of ASX Limited (ASX)? ASX Limited's (ASX) current share price is $66.98. This constitutes a price movement of 7.20% when compared to the share price 7 days ago and is ...